Omalizumab - CISMeF

Preferred Label : Omalizumab;

NCIt synonyms : Olizumab; Anti-IgE Monoclonal Antibody E25; rhuMAb-E25;

NCIt definition : A humanized monoclonal antibody directed against the C-epsilon 3 domain of immunoglobulin E. Olizumab binds to this IgE domain, thereby preventing IgE from binding to its high-affinity mast-cell receptor. (NCI04);

UNII : 2P471X1Z11;

CAS number : 242138-07-4;

Drug name : Xolair;

Molecule name : IGE 025;

Details

Origin ID

C29299;

UMLS CUI

C0966225;

Automatic exact mappings (from CISMeF team)
- rhuMAb-E25 [MeSH concept]
CISMeF manual mappings
- Omalizumab [MeSH Descriptor]
Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Immunologic Factor [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Omalizumab [MeSH Descriptor]
- Omalizumab [Substance BNPC]
- Omalizumab (substance) [SNOMED CT concept]
- Product containing omalizumab (medicinal product) [SNOMED CT concept]
- omalizumab [ATC Code]
- omalizumab [MeSH concept]
Validated automatic mappings to BTNT
- omalizumab [ATC Code]
chemical_or_drug_has_mechanism_of_action
- Antigen Binding [NCIt concept]
concept_is_in_subset
- FDA Established Names and Unique Ingredient Identifier Codes Terminology [NCIt concept]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients